Actionable news
0
All posts from Actionable news
Actionable news in BDSI: BioDelivery Sciences International, Inc.,

BioDelivery Sciences Investors Have Been Burned, But Inflection Point Could Be Coming

View photo

.
  • The share price of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) has increased 15.01 percent over the last five trading days.
  • Roth Capital’s Scott R. Henry has maintained a Buy rating on the company, with a price target of $14.
  • Henry believes that an inflection point could be imminent, following the recent signing of a two-year contract with Tennessee Medicaid, which makes Bunavail the preferred treatment for opioid dependence.

Analyst Scott Henry explained that “Bunavail (buprenorphine/naloxone) is a buccal film for the treatment of opioid addiction. It has potential...


More